| Literature DB >> 26167849 |
Abstract
Tuberculosis (TB) is an ancient disease, but not a disease of the past. The increasing prevalence of drug-resistant strains of Mycobacterium tuberculosis, the causative agent of TB, demands new measures to combat the situation. Rapid and accurate detection of the pathogen, and its drug susceptibility pattern, is essential for timely initiation of treatment, and ultimately, control of the disease. Molecular-based methods offer a great chance to improve detection of drug-resistant TB; however, their development and usage should be accompanied with a profound understanding of drug resistance mechanisms and circulating M. tuberculosis strains in specific settings, as otherwise, the usefulness of such tests may be limited. This review gives an overview of the history of TB treatment and drug resistance, drug resistance mechanisms for the most commonly used drugs and molecular methods designed to detect drug-resistant strains.Entities:
Keywords: MDR-TB; XDR-TB; drug resistance; infection control; next-generation; sequencing
Mesh:
Substances:
Year: 2015 PMID: 26167849 DOI: 10.3109/23744235.2015.1061205
Source DB: PubMed Journal: Infect Dis (Lond) ISSN: 2374-4243